CDSCO (Central Drugs Standard Control Organisation)

CDSCO, the Central Drugs Standard Control Organisation, is India's national regulatory authority for pharmaceuticals and medical devices under the Ministry of Health and Family Welfare, whose approvals and registrations are non-negotiable compliance prerequisites for any supplier bidding on government drug or medical device tenders.

What is CDSCO?

CDSCO functions under the Drugs and Cosmetics Act, 1940, and exercises regulatory control over:

• Approval of new drugs and clinical trials
• Import licences for drugs and medical devices
• Market authorisation for Class C and D medical devices
• Quality control standards for pharmaceuticals
• Cosmetics regulation

From a procurement perspective, CDSCO documents that appear in government tender eligibility requirements include:

• Import Licence (Form 10): Required for importing any notified drug or medical device for supply to government hospitals
• Manufacturing Licence: State Licensing Authority (SLA) issues manufacturing licences; CDSCO has concurrent jurisdiction for certain Class C/D devices and new drug formulations
• New Drug Approval: Required for formulations approved after 1988 not included in the standard pharmacopoeia
• Medical Device Registration: Class B, C, D devices must be registered with CDSCO before import or sale
• Test Licence: Required for importing samples for evaluation and trials

Government tender technical qualification sections invariably include CDSCO documentation requirements. Bids without valid CDSCO approvals covering the exact products being supplied are technically disqualified regardless of price competitiveness.

Why CDSCO matters for Indian government suppliers

CDSCO compliance is the non-negotiable baseline for the entire healthcare procurement market. The 2017 Medical Devices Rules and subsequent amendments have expanded mandatory registration to most medical device categories. Suppliers who build a comprehensive CDSCO registration portfolio across their product range are positioned to respond quickly to government tenders without approval delays.

Example

A medical device company wants to supply cardiac stents to government hospitals under a central procurement tender. The NIT requires a valid CDSCO Class D device registration for the specific stent model. The company's CDSCO registration is for an earlier generation product; it must apply for registration of the new generation stent and wait for approval (typically 3-6 months) before it can bid. Companies that maintain current CDSCO registrations for all marketed products avoid this bottleneck.

Frequently Asked Questions

Which medical devices require CDSCO registration before government supply?

All Class B, C, and D medical devices notified under the Medical Devices Rules 2017 and its amendments require CDSCO registration. Class A (low-risk) devices like bandages and hospital furniture do not require CDSCO registration. The notified list has expanded progressively and covers most diagnostic equipment, implants, and therapeutic devices.

How long does CDSCO medical device registration take?

Registration timelines vary: Class B devices typically 30 days, Class C 45 days, Class D 60 days for import registration under normal processing. Applications through the SUGAM portal (cdsco.gov.in) enable online tracking. Deficiency queries add to timelines. Companies plan 3-6 months buffer for new registrations.

Does a state drug licence replace CDSCO registration?

No. State drug licences (Manufacturing Licence, Sale Licence) are separate from CDSCO registration. For medical devices, CDSCO registration and the state licence are both required. For imported drugs, CDSCO import licence and the state import licence are both needed.

Can distributors hold CDSCO approvals or must manufacturers hold them?

Import licences under Form 10 are held by the Indian importer (which can be a distributor or Indian subsidiary). Manufacturing licences are held by the manufacturer. Device registrations can be held by the manufacturer or their Indian authorised agent. Tender bids must demonstrate a valid chain of CDSCO approvals from manufacturer through to the bidding entity.